ArticleFrontiers in immunology2018

Targeting Sphingosine Kinase Isoforms Effectively Reduces Growth and Survival of Neoplastic Mast Cells With D816V-KIT.

Geethani Bandara et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.